Diagnos Laboratorium Utama Tbk. vs Pembangunan Jaya Ancol Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Pembangunan Jaya Ancol Tbk. trades at Rp462 (market cap 732.8B, 23.9K 24h volume). The key difference: Pembangunan Jaya Ancol Tbk. is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 23.9K). Which is the better fit depends on your goals.
| DGNS | PJAA | |
|---|---|---|
Market Cap | 310.75B | 732.8B |
Volume | 963.6K | 23.9K |
Lot | 9.64K | 239 |
Turnover | 217.67M | 11M |
Average Price | 225.89 | 460.07 |
Value | 217.67M | 11M |
Indicative Equilibrium Price | 226 | 462 |
Indicative Equilibrium Volume | 1K | 5 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pembangunan Jaya Ancol (Company) was established base on notarial deed No. 33 of Achmad Abid SH, dated July 10, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 13 of Mrs. Aulia Taufani, S.H., dated April 01, 2004.
Read more on PJAA →